Ascendis Pharma A/S - Common Stock (ASND)

CUSIP: 04351P101

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
61,152,075
Total 13F shares
64,677,198
Share change
+112,234
Total reported value
$13,781,007,160
Put/Call ratio
31%
Price per share
$213.24
Number of holders
304
Value change
+$36,599,194
Number of buys
172
Number of sells
127

Quarterly Holders Quick Answers

What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
17%
10,281,496
$2,044,064,220 30 Sep 2025
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13D/G 13F
Westfield Capital Management Company, L.P. · Company
8.5%
5,185,696
$1,115,183,925 -$73,663,872 31 Dec 2025
Avoro Capital Advisors LLC
13F
Company
8.4%
5,110,000
$1,015,919,100 30 Sep 2025
13F
FMR LLC
13F 13D/G
Company
8%
from 13D/G
4,471,733
$889,025,151 30 Sep 2025
JANUS HENDERSON GROUP PLC
13D/G 13F
Company
7.8%
4,323,059
$859,467,360 -$20,821,968 30 Sep 2025
Artisan Partners Limited Partnership
13F 13D/G
Company · Artisan Partners Asset Management Inc.
5.2%
from 13D/G
3,720,880
$739,748,153 30 Sep 2025
Capital International Investors
13F 13D/G
Company
5.6%
from 13D/G
3,060,616
$608,481,067 30 Sep 2025
T. Rowe Price Investment Management, Inc.
13D/G 13F
Company
4.8%
2,667,563
$530,338,200 -$182,106,580 30 Sep 2025
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
3.1%
1,882,781
$374,315,689 30 Sep 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.9%
1,798,931
$357,645,472 30 Sep 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.8%
1,726,228
$343,192,000 30 Sep 2025
13F
FRANKLIN RESOURCES INC
13F
Company
2.6%
1,589,956
$316,099,066 30 Sep 2025
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.8%
1,088,501
$216,404,884 30 Sep 2025
13F
Invesco Ltd.
13F
Company
1.5%
917,903
$182,488,296 30 Sep 2025
13F
Polar Capital Holdings Plc
13F
Company
1.4%
857,911
$170,561,286 30 Sep 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
1.3%
793,677
$157,790,924 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
653,012
$129,825,315 30 Sep 2025
13F
Vestal Point Capital, LP
13F
Company
0.98%
600,000
$119,286,000 30 Sep 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.92%
562,936
$111,917,306 30 Sep 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.89%
544,606
$108,274,297 30 Sep 2025
13F
FIL Ltd
13F
Company
0.75%
459,340
$91,321,385 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
0.74%
451,497
$89,762,118 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.67%
406,761
$80,868,155 30 Sep 2025
13F
Spyglass Capital Management LLC
13F
Company
0.64%
388,647
$77,266,910 30 Sep 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.61%
375,899
$74,732,480 30 Sep 2025
13F
MACQUARIE GROUP LTD
13F
Company
0.51%
309,539
$61,539,000 30 Sep 2025
13F
TD ASSET MANAGEMENT INC
13F
Company
0.48%
296,346
$58,916,548 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.48%
292,396
$58,131,249 30 Sep 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.47%
290,172
$57,689,095 30 Sep 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.39%
238,531
$47,422,348 30 Sep 2025
13F
Siren, L.L.C.
13F
Individual
0.39%
235,862
$46,891,724 30 Sep 2025
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.38%
234,397
$46,600,468 30 Sep 2025
13F
Rock Springs Capital Management LP
13F
Company
0.35%
214,500
$42,644,745 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.34%
209,298
$41,610,503 30 Sep 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.34%
208,931
$41,537,572 30 Sep 2025
13F
SEI INVESTMENTS CO
13F
Company
0.34%
205,319
$40,819,523 30 Sep 2025
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.31%
191,672
$39,122,172 30 Sep 2025
13F
UBS Group AG
13F
Company
0.32%
195,204
$38,808,508 30 Sep 2025
13F
ORBIMED ADVISORS LLC
13F
Company
0.31%
191,905
$38,152,633 30 Sep 2025
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.31%
189,654
$37,705,000 30 Sep 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.3%
183,886
$36,558,376 30 Sep 2025
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.29%
179,168
$35,620,390 30 Sep 2025
13F
S.c.a. Candriam
13F
Individual
0.29%
178,956
$35,578,242 30 Sep 2025
13F
ARS Investment Partners, LLC
13F
Company
0.29%
175,667
$34,924,356 30 Sep 2025
13F
Tri Locum Partners LP
13F
Company
0.29%
174,829
$34,757,753 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.29%
174,603
$34,712,822 30 Sep 2025
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.28%
170,701
$33,937,066 30 Sep 2025
13F
Q Global Advisors, LLC
13F
Company
0.28%
170,000
$33,798,000 30 Sep 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.28%
169,894
$33,776,626 30 Sep 2025
13F
Resolute Capital Asset Partners LLC
13F
Company
0.27%
165,672
$32,937,250 30 Sep 2025
13F

Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q4 2025

As of 31 Dec 2025, Ascendis Pharma A/S - Common Stock (ASND) was held by 304 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,677,198 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, FMR LLC, JANUS HENDERSON GROUP PLC, Artisan Partners Limited Partnership, Capital International Investors, FRANKLIN RESOURCES INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 304 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
279
Q4 2025 holders
304
Holder diff
25
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.